億晶光電(600537.SH):擬與中山公用旗下公司設光伏產業合資公司
格隆匯3月14日丨億晶光電(600537.SH)公佈,為進一步拓展公司在分佈式光伏領域的業務,提高公司分佈式光伏裝機容量,增強包括EPC在內的光伏電站建設及運維能力,同時藉助中山公用的豐富資源,公司控股子公司常州億晶光電科技有限公司(“常州億晶”)將與中山公用事業集團股份有限公司(“中山公用”)全資子公司中山公用環保產業投資有限公司(“公用環投”)共同投資人民幣1億元設立光伏產業合資公司(最終以工商登記為準,“合資公司”),其中常州億晶出資3000萬元,佔註冊資本的30%,公用環投出資7000萬元,佔註冊資本的70%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.